Efficacy and safety of fixed‐ratio combination insulin degludec/liraglutide in type 2 diabetes: A systematic review and meta‐analysis of randomised controlled trials
Rui Wang,
Shuoming Luo,
Zilin Xiao
et al.
Abstract:BackgroundThe efficacy and safety of fixed‐ratio combination insulin degludec/liraglutide (IDegLira) for type 2 diabetes (T2DM) were extensively investigated by the global DUAL trials. However, the evidence on its efficacy and safety in T2DM has not been systematically reviewed.MethodsRandomized controlled trials published in English that compared IDegLira with placebo or GLP‐1 agonists or insulin in patients with T2DM were selected up to December 2022. Data on the study characteristics, efficacy and safety ou… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.